GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Ajanta Pharma Ltd (BOM:532331) » Definitions » Cyclically Adjusted Revenue per Share

Ajanta Pharma (BOM:532331) Cyclically Adjusted Revenue per Share : ₹244.85 (As of Mar. 2024)


View and export this data going back to 2000. Start your Free Trial

What is Ajanta Pharma Cyclically Adjusted Revenue per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

Ajanta Pharma's adjusted revenue per share for the three months ended in Mar. 2024 was ₹83.663. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹244.85 for the trailing ten years ended in Mar. 2024.

During the past 12 months, Ajanta Pharma's average Cyclically Adjusted Revenue Growth Rate was 8.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

As of today (2024-05-31), Ajanta Pharma's current stock price is ₹2393.90. Ajanta Pharma's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₹244.85. Ajanta Pharma's Cyclically Adjusted PS Ratio of today is 9.78.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Ajanta Pharma was 9.89. The lowest was 5.23. And the median was 6.92.


Ajanta Pharma Cyclically Adjusted Revenue per Share Historical Data

The historical data trend for Ajanta Pharma's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ajanta Pharma Cyclically Adjusted Revenue per Share Chart

Ajanta Pharma Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 225.21 244.85

Ajanta Pharma Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 225.21 232.98 237.27 242.37 244.85

Competitive Comparison of Ajanta Pharma's Cyclically Adjusted Revenue per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Ajanta Pharma's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ajanta Pharma's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Ajanta Pharma's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Ajanta Pharma's Cyclically Adjusted PS Ratio falls into.



Ajanta Pharma Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Ajanta Pharma's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=83.663/153.0345*153.0345
=83.663

Current CPI (Mar. 2024) = 153.0345.

Ajanta Pharma Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 24.376 94.103 39.642
201409 28.167 96.780 44.539
201412 30.883 96.780 48.834
201503 26.245 97.163 41.337
201506 29.636 99.841 45.426
201509 33.449 101.753 50.306
201512 36.115 102.901 53.710
201603 32.617 102.518 48.689
201606 36.039 105.961 52.049
201609 39.083 105.961 56.446
201612 40.351 105.196 58.701
201703 36.103 105.196 52.521
201706 35.837 107.109 51.203
201709 40.917 109.021 57.436
201712 44.479 109.404 62.217
201803 40.184 109.786 56.014
201806 38.706 111.317 53.212
201809 41.224 115.142 54.791
201812 36.740 115.142 48.831
201903 36.086 118.202 46.720
201906 46.764 120.880 59.203
201909 49.089 123.175 60.989
201912 49.731 126.235 60.289
202003 50.100 124.705 61.481
202006 51.040 127.000 61.503
202009 54.675 130.118 64.304
202012 57.679 130.889 67.438
202103 53.518 131.771 62.154
202106 57.644 134.084 65.791
202109 68.186 135.847 76.813
202112 64.532 138.161 71.479
202203 62.920 138.822 69.362
202206 74.225 142.347 79.798
202209 73.203 144.661 77.440
202212 75.857 145.763 79.641
202303 68.818 146.865 71.709
202306 81.097 150.280 82.583
202309 81.622 151.492 82.453
202312 87.715 152.924 87.778
202403 83.663 153.035 83.663

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.


Ajanta Pharma  (BOM:532331) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Ajanta Pharma's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=2393.90/244.85
=9.78

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of Ajanta Pharma was 9.89. The lowest was 5.23. And the median was 6.92.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


Ajanta Pharma Cyclically Adjusted Revenue per Share Related Terms

Thank you for viewing the detailed overview of Ajanta Pharma's Cyclically Adjusted Revenue per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Ajanta Pharma (BOM:532331) Business Description

Industry
Traded in Other Exchanges
Address
Ajanta House, 98 Government Industrial Area, Charkop, Kandivli (West), Mumbai, MH, IND, 400 067
Ajanta Pharma Ltd is a drug manufacturing company with a focus on specialty pharmaceutical products. The company maintains a global presence while generating the vast majority of its revenue in Africa and India. Ajanta's strategy aims to successfully select molecules and products for development while enhancing its research and development capabilities. The company works to develop formulations in different dosages such as tablets, cream, capsules, liquid, and lotion. The company's manufacturing plants are located in India.

Ajanta Pharma (BOM:532331) Headlines

No Headlines